GAM Holding’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25,146
| Closed | -$764K | – | 272 |
|
|
2022
Q2 | $764K | Hold |
25,146
| – | – | 0.05% | 193 |
|
|
2022
Q1 | $824K | Hold |
25,146
| – | – | 0.04% | 208 |
|
|
2021
Q4 | $663K | Sell |
25,146
-1,813
| -7% | -$47.8K | 0.03% | 221 |
|
|
2021
Q3 | $2.71M | Hold |
26,959
| – | – | 0.13% | 160 |
|
|
2021
Q2 | $3.82M | Sell |
26,959
-4,141
| -13% | -$586K | 0.17% | 145 |
|
|
2021
Q1 | $3.1M | Buy |
+31,100
| New | +$3.1M | 0.14% | 167 |
|
|
2020
Q4 | – | Sell |
-66,750
| Closed | -$6.5M | – | 346 |
|
|
2020
Q3 | $6.5M | Hold |
66,750
| – | – | 0.39% | 79 |
|
|
2020
Q2 | $10.4M | Hold |
66,750
| – | – | 0.65% | 34 |
|
|
2020
Q1 | $9.64M | Sell |
66,750
-4,500
| -6% | -$650K | 0.65% | 35 |
|
|
2019
Q4 | $14.6M | Sell |
71,250
-19,800
| -22% | -$4.05M | 0.69% | 32 |
|
|
2019
Q3 | $7.31M | Hold |
91,050
| – | – | 0.32% | 82 |
|
|
2019
Q2 | $8.59M | Hold |
91,050
| – | – | 0.34% | 71 |
|
|
2019
Q1 | $7.78M | Buy |
91,050
+35,650
| +64% | +$3.05M | 0.33% | 80 |
|
|
2018
Q4 | $3.11M | Buy |
55,400
+800
| +1% | +$44.9K | 0.16% | 152 |
|
|
2018
Q3 | $4.46M | Buy |
54,600
+8,500
| +18% | +$695K | 0.16% | 158 |
|
|
2018
Q2 | $1.61M | Buy |
+46,100
| New | +$1.61M | 0.06% | 333 |
|